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A Drive-thru Anticoagulation Testing Clinic during COVID-19 Pandemic
By: Tina Hyman, MSN, RN-BC; Nohemi Sadule-Rios, PhD, APRN; Robert P. Ramirez, BSN, RN-BC
ABSTRACT
As COVID-19 started to spread rapidly in their community, a team of nurses at South Miami Hospital
initiated a drive-thru anticoagulation testing process to provide safe access to care for patients on anticoagulation therapy, requiring Internationalized Ratio (INR) testing. This article describes the implementation of a drive-thru anticoagulation testing process and implications for best practices during a
pandemic crisis.
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BACKGROUND

Figure 1

COVID-19 has significantly changed
healthcare delivery. As the novel coronavirus,
SARS-CoV-2, started to spread rapidly around
the world, scientists tried to understand the transmissibility of this virus and governments began
to implement measures to slow down the pandemic. A study on the first known person-toperson transmission of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in the
United States of America revealed that extended,
unprotected exposure led to COVID-19 transmission from one individual to another (Ghinai
et al., 2020). Another study indicated that transmissions occurred in community settings (Pung
et al., 2020). More evidence suggested the transmissibility of the virus by asymptomatic and preasymptomatic carriers (Huff & Singh, 2020).

Anticoagulation clinic team

Following the Centers for Disease Control
(CDC) and states’ recommendations, healthcare
systems in the United States implemented rigorous measures to protect human lives and prevent
the transmission of COVID-19. Some of the
safety measures implemented immediately by
the Anticoagulation Clinic included restricting
visitors, social distancing, mandating face covering, and ensuring employees’ appropriate use of
personal protective equipment (PPE).

FACING THE CHALLENGE
The Anticoagulation Clinic opened in 2007,
and grew quickly, exceeding 500 patient visits
monthly. The clinic improved patient outcomes,
reduced warfarin-related adverse drug reactions
(ADRs), and warfarin-related hospital readmissions by 71%. However, once SARS-CoV-2
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invaded the lives of Americans, the clinic’s patient care process was no longer effective. The
census dropped acutely from the once normal 25
– 30 patient visits to 10 patient visits daily, as the
pandemic spread into Miami-Dade County. Consequently, a team of nurses caring for these patients, consisting of a nurse manager, an office
supervisor, two advanced practice registered
nurses (APRN), four registered nurses (RN), a
clinical educator, and four clerical staff members
became increasingly concerned for their longterm patients needing INR testing for safe anticoagulation therapy (Figure 1). According to The
Joint Commission National Patient Safety Goal
NPSG.03.03.01, EP 1, anticoagulation medications have a higher risk for causing harm to patients due to the complex dosing, insufficient
monitoring, and poor patient compliance making
the clinic’s efforts to keep their patients safe vitally important (The Joint Commission, 2018).

Figure 2
Anticoagulation clinic new testing process

NURSES INGENUITY TO CARE FOR
PATIENTS
The clinic’s team rallied to ensure patients
were and felt safe despite the great stress and
fear that the COVID-19 had brought. Along with
the reports that drive-thru COVID-19 testing had
become available in other parts of the country,
the clinic’s educator suggested a drive-thru testing process for the Anticoagulation Clinic
patients. As soon as the team received approval
by key administrators, a new process arose from
the pandemic crisis.
With the new process, patients do not need
to come into the hospital clinic to receive testing
and care (Figure 2). The day before appointments, nurses make reminder calls as usual, with
additional dialogue that included new COVID-19
screening questions, location of the drive-thru
site, requirement of wearing facial covering/
mask, and instructions to lower only the patient’s
window to prevent airborne exposure from a
draft during the appointment. Upon arrival, the
patient’s temperature is checked, registration
process is completed, two required patient identifiers are confirmed with the patient, and the point
of care equipment is prepared. The nurses wear
CDC recommended PPE during any transactions
with the patients. Additionally, nurses provide
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diet recommendations, medication education,
and address patients’ concerns as the capillary
sample is collected. Using the point of care
equipment, the INR result along with any
pertinent information is then reported via phone
to one of the two registered nurses (RNs) seated
inside the clinic. The receiving RNs already have
the patient’s account and visit history available
on their computer monitors. They determine
whether medication dosing changes are necessary, seek feedback from the APRN, reconcile
the home medication list, document any information received on the patient through report,
and schedule the next visit.

The drive-thru anticoagulation testing process provides patients with both a convenient and
safe testing environment to alleviate the fear of
entering the hospital as well as a sense of normalcy that comes with seeing the familiar nurses’ faces and receiving the professional care to
which they are accustomed. This sentiment has
been echoed by the resounding “thank-you”
appreciations received from the patients who
have trusted the RNs’ guidance with their theraBaptist Health South Florida

16

Hyman et al.: A Drive-thru Anticoagulation Testing Clinic during COVID-19 Pande

COVID-19 Special Edition
py prior to and now, during this COVID-19 pandemic crisis.
IMPACT OF THE DRIVE-THROUGH ANTI
-COAGULATION CLINIC
Results from a recent patient satisfaction survey administered to the clinic patients indicated
that most of the surveyed patients (61%) would
not have come to their regular clinic visit inside
the hospital and that they had no intention of getting checked anywhere else until after the pandemic had passed. All surveyed patients gave the
drive-through clinic new testing process the highest satisfaction score. Clinic patients were also
satisfied with the drive-thru turnaround time,
which is considerably less than the traditional
process. A routine visit that used to take between
30 to 45 minutes to park, register, wait, and be
seen now takes, on average, less than of < 15
minutes.
CONCLUSION AND IMPLICATIONS FOR
PRACTICE

The drive-thru anticoagulation testing process was created to provide safe and effective
care for patients taking warfarin. Since social
distancing is one of the most essential strategies
to prevent transmission of the virus (Qian &
Jiang, 2020), driving-thru instead of coming into
the clinic, helped our patients feel safe and at
ease. Moreover, the use of masks provides effective protection against the virus (Lianga et al.,
2020). The team knew that their patients’ lives
were at risk if they were not being managed appropriately during the COVID-19 pandemic. By
implementing an innovative drive-through process to facilitate INR testing, the patient experience has improved, and the number of cancellations has decreased. Furthermore, the clinic staff
continues to work with minimum adjustments to
their daily routine.
This initiative exemplifies the values, mission, and vision of this healthcare system and of
the leaders who uphold and prioritize the lives of
the patients and community served every day,
even during the chaos caused by a global pandemic.
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